KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 3.123
AS - Asia 1.587
EU - Europa 1.172
SA - Sud America 367
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.355
Nazione #
US - Stati Uniti d'America 3.048
SG - Singapore 475
RU - Federazione Russa 332
VN - Vietnam 299
BR - Brasile 295
IT - Italia 293
CN - Cina 259
HK - Hong Kong 239
BD - Bangladesh 117
FR - Francia 109
IE - Irlanda 109
SE - Svezia 88
GB - Regno Unito 67
IN - India 56
DE - Germania 42
CA - Canada 39
CI - Costa d'Avorio 36
AR - Argentina 25
FI - Finlandia 24
MX - Messico 23
PL - Polonia 23
AT - Austria 20
NL - Olanda 20
ZA - Sudafrica 19
IQ - Iraq 16
TR - Turchia 15
ID - Indonesia 13
JP - Giappone 13
EC - Ecuador 12
ES - Italia 12
MA - Marocco 12
PY - Paraguay 10
VE - Venezuela 10
PH - Filippine 9
PK - Pakistan 9
CO - Colombia 7
SA - Arabia Saudita 7
TH - Thailandia 7
DZ - Algeria 6
KE - Kenya 6
UA - Ucraina 6
UZ - Uzbekistan 6
EG - Egitto 5
JM - Giamaica 5
JO - Giordania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
KR - Corea 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
CL - Cile 3
ET - Etiopia 3
EU - Europa 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
TT - Trinidad e Tobago 1
Totale 6.355
Città #
Ashburn 660
Des Moines 380
Chandler 310
Singapore 309
San Jose 308
Hong Kong 233
Dallas 118
Dublin 108
Boardman 99
Ho Chi Minh City 86
Hanoi 71
Beijing 68
Fairfield 68
The Dalles 64
Lauterbourg 60
Los Angeles 59
New York 50
Moscow 44
Hefei 39
Milan 38
Abidjan 36
Ancona 35
Buffalo 30
Lawrence 30
Princeton 30
San Mateo 28
Wilmington 28
Council Bluffs 25
Pune 25
Houston 23
Orem 23
São Paulo 22
Turin 22
Helsinki 21
Rome 21
Seattle 21
Woodbridge 21
Warsaw 20
Nuremberg 19
Falls Church 18
Cambridge 16
Marche 16
Montreal 16
Phoenix 16
Chicago 15
Rio de Janeiro 15
Da Nang 14
Ann Arbor 13
Santa Clara 13
Frankfurt am Main 12
Tokyo 12
Vienna 12
Columbus 11
Haiphong 11
San Diego 11
Stockholm 11
Denver 10
Washington 10
Manchester 9
Naples 9
San Francisco 9
Shanghai 9
Amsterdam 8
Boston 8
Brasília 8
Chennai 8
London 8
Toronto 8
Ankara 7
Atlanta 7
Brooklyn 7
Johannesburg 7
Mexico City 7
Norwalk 7
Bangkok 6
Bologna 6
Dong Ket 6
Falconara Marittima 6
Guayaquil 6
Istanbul 6
Miano 6
Tashkent 6
Amman 5
Baghdad 5
Campinas 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Medellín 5
Portsmouth 5
Southwark 5
Asunción 4
Belo Horizonte 4
Bến Tre 4
Cape Town 4
Dhaka 4
Elk Grove Village 4
Guarulhos 4
Hangzhou 4
Jakarta 4
Totale 4.159
Nome #
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 198
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 164
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 150
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 138
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 137
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 137
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 133
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 127
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 126
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues. Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 122
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 121
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 121
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 117
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 117
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 114
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 113
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 113
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 111
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 111
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 110
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 110
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 109
Cluster stability in the analysis of mass cytometry data 107
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 106
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 101
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 100
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 100
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 99
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 98
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 98
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 96
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 94
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 91
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy 90
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 90
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 89
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 88
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 86
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 85
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 85
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 84
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 82
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 82
Natural born survivors: The inglorious TP53 80
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 77
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 72
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 71
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 71
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 68
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 67
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 67
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 65
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 65
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 63
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 63
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 62
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 61
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 61
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 60
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 60
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 59
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 56
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 55
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 54
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 54
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 53
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 52
Functional characterization of CD4+ T cells in aplastic anemia 52
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 51
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 51
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 50
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 46
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia 4
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM‐prognostic score (FCM‐PS) for overall survival 3
High frequency of CD95 + / CD45RA − regulatory T cells defines an immunosuppressive profile associated with MDS progression 3
Totale 6.526
Categoria #
all - tutte 31.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 0 0 0 0 0 0 39
2021/2022331 2 79 0 1 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/20251.241 75 117 46 18 47 73 202 64 254 74 111 160
2025/20263.381 170 169 174 207 322 236 654 328 345 351 236 189
Totale 6.526